Zentek Ltd. Overview
Pro stress-test →Zentek is a Canadian company advancing a portfolio of graphene-enabled advanced material technologies across healthcare, clean air and next-generation industrial applications. The company is engaged in research and development of graphene and related nanomaterials in Canada and owns 100% interest in the Albany Graphite Project located in Northern Ontario.
Strategic Profile
Pro stress-test →Zentek is at the forefront of developing nanotechnology-enabled solutions in areas such as indoor air quality, health and safety, anti-corrosion, and reduction of carbon emissions. With graphite designated as a NATO defence-critical raw material essential for tanks, naval vessels and submarines, Zentek's Albany project is strategically positioned to benefit from government support and non-dilutive funding opportunities.
Competitive Landscape
Pro stress-test →Zentek collaborates with over 100 researchers across a dozen universities in Canada and globally on graphene and nanotechnology research, positioning it within a broader ecosystem. Competitors in graphene/graphite include companies like Graphite Energy and other critical minerals developers, though Zentek's focus on both medical-grade applications (ZenGUARD) and mining (Albany) creates a diversified competitive position.
Industry Context
Zentek Ltd. operates in Advanced Materials / Critical Minerals / Graphene Technology / Healthcare Technology.
Key facts
Founded: 2008 · Headquarters: Guelph, Canada · Employees: 18 · Market cap: $63.35M